메뉴 건너뛰기




Volumn 118, Issue 8, 2012, Pages 1971-1981

18F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: A systematic review

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

EID: 84859631459     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26467     Document Type: Review
Times cited : (111)

References (28)
  • 1
    • 70349303765 scopus 로고    scopus 로고
    • International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
    • Dimopoulos M, Terpos E, Comenzo RL, et al. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia. 2009; 23: 1545-1556.
    • (2009) Leukemia , vol.23 , pp. 1545-1556
    • Dimopoulos, M.1    Terpos, E.2    Comenzo, R.L.3
  • 2
    • 0016804136 scopus 로고
    • A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
    • Durie BG, Salmon SE,. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975; 36: 842-854.
    • (1975) Cancer , vol.36 , pp. 842-854
    • Durie, B.G.1    Salmon, S.E.2
  • 3
    • 70349231349 scopus 로고    scopus 로고
    • F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
    • Bartel TB, Haessler J, Brown TLY, et al. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood. 2009; 114: 2068-2076.
    • (2009) Blood , vol.114 , pp. 2068-2076
    • Bartel, T.B.1    Haessler, J.2    Brown, T.L.Y.3
  • 4
    • 33846916461 scopus 로고    scopus 로고
    • A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma
    • Zamagni E, Nanni C, Patriarca F, et al. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica. 2007; 92: 50-55.
    • (2007) Haematologica , vol.92 , pp. 50-55
    • Zamagni, E.1    Nanni, C.2    Patriarca, F.3
  • 5
    • 0030935125 scopus 로고    scopus 로고
    • PET in oncology: Will it replace the other modalities?
    • Hoh CK, Schiepers C, Seltzer MA, et al. PET in oncology: will it replace the other modalities? Semin.Nucl.Med. 1997; 27: 94-106.
    • (1997) Semin.Nucl.Med , vol.27 , pp. 94-106
    • Hoh, C.K.1    Schiepers, C.2    Seltzer, M.A.3
  • 9
    • 38949145120 scopus 로고    scopus 로고
    • Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown significance
    • Adam Z, Bolcak K, Stanicek J, et al. Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown significance. Neoplasma. 2007; 54: 536-540.
    • (2007) Neoplasma , vol.54 , pp. 536-540
    • Adam, Z.1    Bolcak, K.2    Stanicek, J.3
  • 12
    • 75149129097 scopus 로고    scopus 로고
    • The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: A comparative study with Tc-99m sestamibi
    • Castellani M, Carletto M, Baldini L, et al. The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi. Clin Nucl Med. 2010; 35: 1-5.
    • (2010) Clin Nucl Med , vol.35 , pp. 1-5
    • Castellani, M.1    Carletto, M.2    Baldini, L.3
  • 14
    • 38949108583 scopus 로고    scopus 로고
    • 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma
    • Fonti R, Salvatore B, Quarantelli M, et al. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma. J Nucl Med. 2008; 49: 195-200.
    • (2008) J Nucl Med , vol.49 , pp. 195-200
    • Fonti, R.1    Salvatore, B.2    Quarantelli, M.3
  • 15
    • 28444462083 scopus 로고    scopus 로고
    • Comparison of Tc-99m sestamibi and F-18 FDG-PET in the assessment of multiple myeloma
    • Hung GU, Tsai CC, Tsai SC, Lin WY,. Comparison of Tc-99m sestamibi and F-18 FDG-PET in the assessment of multiple myeloma. Anticancer Res. 2005; 25: 4737-4741.
    • (2005) Anticancer Res , vol.25 , pp. 4737-4741
    • Hung, G.U.1    Tsai, C.C.2    Tsai, S.C.3    Lin, W.Y.4
  • 16
    • 34249780345 scopus 로고    scopus 로고
    • Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: Comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography
    • Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS,. Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography. J ComputAssisted Tomogr. 2007; 31: 342-347.
    • (2007) J ComputAssisted Tomogr , vol.31 , pp. 342-347
    • Hur, J.1    Yoon, C.S.2    Ryu, Y.H.3    Yun, M.J.4    Suh, J.S.5
  • 17
    • 42649139240 scopus 로고    scopus 로고
    • Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma
    • Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS,. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma. Acta Radiol. 2008; 49: 427-435.
    • (2008) Acta Radiol , vol.49 , pp. 427-435
    • Hur, J.1    Yoon, C.S.2    Ryu, Y.H.3    Yun, M.J.4    Suh, J.S.5
  • 18
    • 0036948617 scopus 로고    scopus 로고
    • Diagnostic utility of FDG PET in multiple myeloma
    • Jadvar H, Conti PS,. Diagnostic utility of FDG PET in multiple myeloma. Skelet Radiol. 2002; 31: 690-694.
    • (2002) Skelet Radiol , vol.31 , pp. 690-694
    • Jadvar, H.1    Conti, P.S.2
  • 19
    • 0742269486 scopus 로고    scopus 로고
    • A comparison of fluorine-18 fluorodeoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma
    • Mileshkin L, Blum R, Seymour JF, Patrikeos A, Hicks RJ, Prince HM,. A comparison of fluorine-18 fluorodeoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma. Eur J Haematol. 2004; 72: 32-37.
    • (2004) Eur J Haematol , vol.72 , pp. 32-37
    • Mileshkin, L.1    Blum, R.2    Seymour, J.F.3    Patrikeos, A.4    Hicks, R.J.5    Prince, H.M.6
  • 20
    • 70350099221 scopus 로고    scopus 로고
    • Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET
    • Dimitrakopoulou-Strauss A, Hoffmann M, Bergner R, Uppenkamp M, Haberkorn U, Strauss LG,. Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET. Clin Nucl Med. 2009; 34: 576-584.
    • (2009) Clin Nucl Med , vol.34 , pp. 576-584
    • Dimitrakopoulou-Strauss, A.1    Hoffmann, M.2    Bergner, R.3    Uppenkamp, M.4    Haberkorn, U.5    Strauss, L.G.6
  • 21
    • 33646402351 scopus 로고    scopus 로고
    • Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: Preliminary results
    • Nanni C, Zamagni E, Farsad M, et al. Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. Eur J Nucl Med Mol Imaging 2006; 33: 525-531.
    • (2006) Eur J Nucl Med Mol Imaging , vol.33 , pp. 525-531
    • Nanni, C.1    Zamagni, E.2    Farsad, M.3
  • 22
    • 48749110375 scopus 로고    scopus 로고
    • FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma
    • Salaun PY, Gastinne T, Frampas E, Bodet-Milin C, Moreau P, Bodere-Kraeber F,. FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma. Haematologica 2008; 93: 1269-1271.
    • (2008) Haematologica , vol.93 , pp. 1269-1271
    • Salaun, P.Y.1    Gastinne, T.2    Frampas, E.3    Bodet-Milin, C.4    Moreau, P.5    Bodere-Kraeber, F.6
  • 23
    • 0036202025 scopus 로고    scopus 로고
    • Initial results in the assessment of multiple myeloma using 18F-FDG PET
    • Schirrmeister H, Bommer M, Buck AK, et al. Initial results in the assessment of multiple myeloma using 18F-FDG PET. Eur J Nucl Med. 2002; 29: 361-366.
    • (2002) Eur J Nucl Med , vol.29 , pp. 361-366
    • Schirrmeister, H.1    Bommer, M.2    Buck, A.K.3
  • 25
    • 63849194015 scopus 로고    scopus 로고
    • Whole-body MRI versus PET in assessment of multiple myeloma disease activity
    • Shortt CP, Gleeson TG, Breen KA, et al. Whole-body MRI versus PET in assessment of multiple myeloma disease activity. Am J Roentgenol. 2009; 192: 980-986.
    • (2009) Am J Roentgenol , vol.192 , pp. 980-986
    • Shortt, C.P.1    Gleeson, T.G.2    Breen, K.A.3
  • 26
    • 67349279134 scopus 로고    scopus 로고
    • Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma
    • Kim PJ, Hicks RJ, Wirth A, et al. Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma. Int J Radiat Oncol Biol Phys. 2009; 74: 740-746.
    • (2009) Int J Radiat Oncol Biol Phys , vol.74 , pp. 740-746
    • Kim, P.J.1    Hicks, R.J.2    Wirth, A.3
  • 27
    • 58149307938 scopus 로고    scopus 로고
    • The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials
    • Boellaard R, Oyen WJ, Hoekstra CJ, et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 2008; 35: 2320-2333.
    • (2008) Eur J Nucl Med Mol Imaging , vol.35 , pp. 2320-2333
    • Boellaard, R.1    Oyen, W.J.2    Hoekstra, C.J.3
  • 28
    • 72949107608 scopus 로고    scopus 로고
    • FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: Version 1.0
    • Boellaard R, O'Doherty MJ, Weber WA, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2010; 37: 181-200.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , pp. 181-200
    • Boellaard, R.1    O'Doherty, M.J.2    Weber, W.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.